OpenEvidence
Share
OpenEvidence is the most widely used medical AI platform among U.S. physicians. Free for all verified U.S. clinicians.
Ask a clinical question and get an evidence-based answer in seconds, grounded in NEJM, JAMA, and 300+ journals.
06/09/2026
The American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons, and OpenEvidence, the most widely used medical AI platform among U.S. physicians, today announced a strategic partnership to integrate the Academy’s Preferred Practice Patterns® and Ophthalmic Technology Assessments directly into the OpenEvidence platform.
Still skeptical and don’t want to adopt AI into your clinical practice? Consider this…with nearly 1.5million PubMed publications in the biomedical domain alone every year it is impossible to keep up to date on the literature. OpenEvidence allows you to stay up-to-date on medical literature using a reliable and trustworthy AI tool.
Meet Dr Sam Mullangi one of OpenEvidence’s Oncologists and hear some of her thoughts from this weekends 2026 ASCO meeting in Chicago!
05/27/2026
As a part of OpenEvidence’s commitment to creating advanced AI models for medical specialties, the company has extended their oncology model to include the ASCO Guidelines. ASCO Guidelines will now appear within OpenEvidence answers, accompanied by peer-reviewed evidence, precise citations, and a direct link to the ASCO website.
OpenEvidence introduces speech-to-speech medical AI. This allows you to ask a clinical question out loud as if having a conversation with a colleague. The answer comes back concise, peer-reviewed, and verifiable against the source.
05/20/2026
Until now, clinicians using AI tools had to manually pull together the relevant details of a patient’s case. With patient-aware clinical intelligence, OpenEvidence, the most widely used medical AI and clinical decision making tool among U.S. physicians, works directly within Epic to draw on a patient’s full record — medications, allergies, comorbidities, prior procedures, longitudinal data — and interpret the medical literature through the lens of that specific patient.
Cedars-Sinai is the first academic health system to deploy this at enterprise scale via the OpenEvidence x Cedars-Sinai partnership unifying real-time patient context with the world’s leading medical literature to transform point-of-care decision-making
05/11/2026
The Society of Surgical Oncology (SSO) and OpenEvidence the most widely used medical knowledge platform announced a strategic partnership to strengthen access to the most trusted surgical oncology evidence at the point of care.
05/06/2026
The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence.
Open Evidence in the American College of obstetricians and gynecologist have announced a collaboration to expand access to ACOG’s evidence based clinical guidelines and insights to inform on clinical decisions made at the point of care for women’s health and OB-Gyn
04/30/2026
Another incredible partnership! The American Urological Association and OpenEvidence entered in a partnership that will allow clinicians to surface AUA clinical practice guidelines and consensus statements.
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
215 NW 24th Street
Miami, FL
33127